Cargando…

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma

LncRNA-NEF is a tumor suppressor lncRNA in liver cancer. The present study aimed to investigate the role of lncRNA-NEF in intrahepatic cholangiocarcinoma (IHCC), which is second most common type of primary cancer of the hepatobiliary system that causes high mortality rate. In the present study we fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhanqiang, Zhu, Bingshuai, Meng, Dongdong, Shen, Xiwen, Li, Xuemin, Wang, Zhongzhen, Li, Liantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527927/ https://www.ncbi.nlm.nih.gov/pubmed/31015363 http://dx.doi.org/10.1042/BSR20181573

Ejemplares similares

Upregulated lncRNA‐NEF predicts recurrence and poor treatment outcomes of ankylosing spondylitis
por: Han, Dapeng, et al.
Publicado: (2022)

A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis
por: Li, Fengwei, et al.
Publicado: (2020)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis
por: Zhang, Lin-Ting, et al.
Publicado: (2023)

LncRNA-NEF is downregulated in postmenopausal osteoporosis and is related to course of treatment and recurrence
por: Ma, Xiaoyong, et al.
Publicado: (2019)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Huang, Yu, et al.
Publicado: (2018)

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
por: Xu, Zhiying, et al.
Publicado: (2020)

lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer
por: Chen, Cheng, et al.
Publicado: (2020)

Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
por: Li, Xu, et al.
Publicado: (2020)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Kuang, Jie, et al.
Publicado: (2017)

miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
por: Zheng, Bo, et al.
Publicado: (2017)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
por: Cai, Xiaobo, et al.
Publicado: (2018)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma
por: Romani, Antonello A, et al.
Publicado: (2007)

Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis
por: Dai, Longfei, et al.
Publicado: (2019)

Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma
por: Weng, Shao-Wen, et al.
Publicado: (2021)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
por: Lin, Guohe, et al.
Publicado: (2016)

lncRNA-NEF is downregulated in osteosarcoma and inhibits cancer cell migration and invasion by downregulating miRNA-21
por: Yang, Qinglei, et al.
Publicado: (2019)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma
por: Li, Yongjian, et al.
Publicado: (2022)

High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Jin, Jing, et al.
Publicado: (2014)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
por: Jeong, Seorin, et al.
Publicado: (2017)

Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma
por: Yamashita, Hironori, et al.
Publicado: (2021)

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lno9lkbdofkpj8rfnavkqc75v3